関連する実験動画
Updated: Sep 10, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.8K
COPD,喘息,喘息-COPDの重なり合っている患者の抗酸化能力の比較
Melike Yüksel Yavuz1, Muzaffer Onur Turan1, Hayat Özkanay2
1Pulmonology Department, School of Medicine, İzmir Katip Çelebi University, 35620 İzmir, Türkiye.
Medicina (Kaunas, Lithuania)
|August 28, 2025
まとめ
慢性閉塞性肺疾患 (COPD) の患者は,喘息と喘息とCOPDの重複 (ACO) と比較して,総抗酸化能力 (TAC) が低かった. 低 TACは,COPDと喘息やACOを区別するのに役立ちます.
科学分野:
- 肺医学
- 生物化学
背景:
- 喘息,COPD,および喘息-COPDの重複は,炎症によって特徴づけられる閉塞性肺疾患です.
- 酸化ストレスと抗酸化物質の不均衡は,これらの状態の病原性に関与しています.
研究 の 目的:
- 喘息,COPD,および喘息とCOPDの重複 (ACO) の患者の間で抗酸化能力 (TAC) の違いを調査する.
主な方法:
- 76人の患者を対象とした前向きな横断試験です.
- 生化学分析器と抗酸化物質の総活性法を使用して,空腹の静脈血液サンプルにおける TACの測定.
主要な成果:
- 喘息とACO患者と比較して,COPD患者ではTAC値が有意に低かった (p=0. 049とp=0. 026).
- 現在の喫煙者および以前の喫煙者は,決して喫煙していない人よりもTACレベルが低い (p=0.033).
- TAC値とエオシノフィール数,FEV1,またはFEV1/FVC比率は有意な相関関係が見つかりませんでした.
結論:
- 減少したTACレベルは,COPDと喘息またはACOを区別するための潜在的なバイオマーカーとして機能する.
- 閉塞性肺疾患におけるTACの臨床的有用性を調べるためにさらなる研究が必要である.
さらに関連する動画
関連する概念動画
COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K

